Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Third Quarter 2014 Financial Results and Business Update Conference Call on Thursday, October 30, 2014 at 8:30 AM ET.
To participate in the call, dial 866-952-1907 from the U.S. and Canada or 785-424-1826 from international locations and enter conference ID: TRANS. The call can also be accessed through a link on the Transgenomic website, http://www.videonewswire.com/event.asp?id=100807.
A replay of the call will be available for two weeks beginning approximately two hours after the call’s conclusion until 11:59 PM ET November 13, 2014. To access the replay, dial 800-723-5792 (domestic) or 402-220-2664 (international).
About Transgenomic, Inc.
Transgenomic,
Inc. is a global biotechnology company advancing personalized
medicine in cardiology, oncology, and inherited diseases through
advanced diagnostic technologies, such as its revolutionary ICE COLD-PCRTM
and its unique genetic tests provided through its Patient Testing
business. The company also provides specialized clinical and research
services to biopharmaceutical companies developing targeted therapies
and sells equipment, reagents and other consumables for applications in
molecular testing and cytogenetics. Transgenomic’s diagnostic
technologies are designed to improve medical diagnoses and patient
outcomes.
Contacts:
Argot Partners
Susan Kim,
212-600-1902
susan@argotpartners.com
or
Media
Contact
BLL Partners LLC
Barbara Lindheim, 212-584-2276
blindheim@bllbiopartners.com
or
Company
Contact
Transgenomic, Inc.
Mark Colonnese, 203-907-2242
Executive
Vice President and Chief Financial Officer
investorrelations@transgenomic.com